http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1927908-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ad66884a6f2a66126d492e56e09be39 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J19-00 |
filingDate | 1969-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d63a11ace1c36b634174a606cbfb70e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8b8584f7433149032f78611bdfe1d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4324cd5a52ba95f942ab9457ee6d5ce |
publicationDate | 1970-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DE-1927908-A1 |
titleOfInvention | Process for the preparation of delta, 20,22-bufatrienolide rhamnoside-3'-acylates |
abstract | Compounds of formula:- (where R = Me or HCO; R1, R2 and R3 = H or acyl of at least 2C, one of R1, R2 and R3 at least must = acyl), can be used for treatment of cardiac insufficiency. Preparation is by reaction of the appropriate bufatrienolide rhamnoside with an acid chloride or anhydride in presence of catalysts such as pyridine and metaboric acid, then purification by column chromatography. |
priorityDate | 1969-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.